These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 21806511)
21. Natriuretic peptides and their therapeutic potential. Cho Y; Somer BG; Amatya A Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638 [TBL] [Abstract][Full Text] [Related]
22. Natriuretic peptides in heart valve disease. Ray SG Heart; 2006 Sep; 92(9):1194-7. PubMed ID: 16251227 [TBL] [Abstract][Full Text] [Related]
23. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice]. Boomsma F; van den Meiracker AH Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463 [TBL] [Abstract][Full Text] [Related]
24. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528 [TBL] [Abstract][Full Text] [Related]
25. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure]. Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510 [TBL] [Abstract][Full Text] [Related]
27. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
28. B-type natriuretic peptides: looking to the future. Troughton RW; Lewis LK; Yandle TG; Pemberton CJ; Nicholls MG Ann Med; 2011 May; 43(3):188-97. PubMed ID: 20961274 [TBL] [Abstract][Full Text] [Related]
29. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Hülsmann M; Berger R; Sturm B; Bojic A; Woloszczuk W; Bergler-Klein J; Pacher R Eur Heart J; 2002 Jun; 23(11):886-91. PubMed ID: 12042010 [TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002 [TBL] [Abstract][Full Text] [Related]
31. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure. Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855 [TBL] [Abstract][Full Text] [Related]
32. B-type natriuretic peptides. A diagnostic breakthrough in heart failure. McCullough PA Minerva Cardioangiol; 2003 Apr; 51(2):121-9. PubMed ID: 12783068 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Woods RL Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395 [TBL] [Abstract][Full Text] [Related]
35. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243 [TBL] [Abstract][Full Text] [Related]
36. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
37. Brain natriuretic peptide and acute coronary syndrome. Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538 [TBL] [Abstract][Full Text] [Related]
38. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729 [TBL] [Abstract][Full Text] [Related]
39. Natriuretic peptides in assessment of left-ventricular dysfunction. Mair J; Friedl W; Thomas S; Puschendorf B Scand J Clin Lab Invest Suppl; 1999; 230():132-42. PubMed ID: 10389212 [TBL] [Abstract][Full Text] [Related]
40. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]